Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Plischke

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Transplantation|April 19, 2013
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipientsMarkus Riegersperger, Max Plischke, Sabine Steiner, et al.
Clinical Biochemistry|December 11, 2012
Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patientsManfred Hecking, Alexander Kainz, Bernhard Bielesz, et al.
Trials|July 6, 2013
Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)Martina Gaggl, Daniel Cejka, Max Plischke, et al.
Plos One|July 3, 2019
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypesMarkus Riegersperger, Max Plischke, Anita Jallitsch-Halper, et al.
Clinical Laboratory|February 7, 2017
The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant RecipientsMarkus Riegersperger, Max Plischke, Corinna Steinhauser, et al.
Clinical Biochemistry|June 24, 2014
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patientsBernhard O Bielesz, Manfred Hecking, Max Plischke, et al.
European Journal of Clinical Investigation|December 14, 2011
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failureMax Plischke, Stephanie Neuhold, Christopher Adlbrecht, et al.
European Heart Journal|June 30, 2012
Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk scoreGeorg Goliasch, Marcus E Kleber, Bernhard Richter, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplantation|April 19, 2013
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipientsMarkus Riegersperger, Max Plischke, Sabine Steiner, et al.
Clinical Biochemistry|December 11, 2012
Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patientsManfred Hecking, Alexander Kainz, Bernhard Bielesz, et al.
Trials|July 6, 2013
Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)Martina Gaggl, Daniel Cejka, Max Plischke, et al.
Plos One|July 3, 2019
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypesMarkus Riegersperger, Max Plischke, Anita Jallitsch-Halper, et al.
Clinical Laboratory|February 7, 2017
The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant RecipientsMarkus Riegersperger, Max Plischke, Corinna Steinhauser, et al.
Clinical Biochemistry|June 24, 2014
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patientsBernhard O Bielesz, Manfred Hecking, Max Plischke, et al.
European Journal of Clinical Investigation|December 14, 2011
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failureMax Plischke, Stephanie Neuhold, Christopher Adlbrecht, et al.
European Heart Journal|June 30, 2012
Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk scoreGeorg Goliasch, Marcus E Kleber, Bernhard Richter, et al.
Pageof 2